Status:
COMPLETED
Smoking Cessation in Head and Neck Cancer Patients Receiving Curative Radiation Therapy
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Head and Neck Neoplasms
Eligibility:
All Genders
20-70 years
Phase:
PHASE2
Brief Summary
To propose a feasibility study of introducing a smoking cessation program in head and neck cancer patients with planned radiotherapy. The study will feature the feasibility, safety, and efficacy of a ...
Detailed Description
Smoking during radiotherapy in head and neck cancers yields not only more radiotherapy acute and late complications but also poor clinical tumor response, poor local control, and poor overall survival...
Eligibility Criteria
Inclusion
- Age 18 to 70 years
- Head and Neck Malignancy Stage I-IVB without distant metastasis
- Receiving five weeks or more of external beam radiotherapy
- Report smoking one or more cigarettes in the past 30 days or self-identify as a smoker
- KPS 70-100
Exclusion
- Serious or unstable cardiac, renal, hypertensive, pulmonary, endocrine, or neurologic disorders, as assessed by the study-site physician
- A current diagnosis of major depressive episode or a history of psychosis, bipolar disorder, or seizure disorder
- Pregnancy or lactation
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT02251730
Start Date
August 1 2014
End Date
May 1 2016
Last Update
May 13 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taipei, Taiwan, 100